Correlation Between Monte Rosa and Talaris Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Monte Rosa and Talaris Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Monte Rosa and Talaris Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Monte Rosa Therapeutics and Talaris Therapeutics, you can compare the effects of market volatilities on Monte Rosa and Talaris Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monte Rosa with a short position of Talaris Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monte Rosa and Talaris Therapeutics.

Diversification Opportunities for Monte Rosa and Talaris Therapeutics

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Monte and Talaris is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Monte Rosa Therapeutics and Talaris Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Talaris Therapeutics and Monte Rosa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monte Rosa Therapeutics are associated (or correlated) with Talaris Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Talaris Therapeutics has no effect on the direction of Monte Rosa i.e., Monte Rosa and Talaris Therapeutics go up and down completely randomly.

Pair Corralation between Monte Rosa and Talaris Therapeutics

If you would invest  530.00  in Monte Rosa Therapeutics on August 28, 2024 and sell it today you would earn a total of  316.00  from holding Monte Rosa Therapeutics or generate 59.62% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.48%
ValuesDaily Returns

Monte Rosa Therapeutics  vs.  Talaris Therapeutics

 Performance 
       Timeline  
Monte Rosa Therapeutics 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Monte Rosa Therapeutics are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating basic indicators, Monte Rosa exhibited solid returns over the last few months and may actually be approaching a breakup point.
Talaris Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Talaris Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable essential indicators, Talaris Therapeutics is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Monte Rosa and Talaris Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Monte Rosa and Talaris Therapeutics

The main advantage of trading using opposite Monte Rosa and Talaris Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monte Rosa position performs unexpectedly, Talaris Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Talaris Therapeutics will offset losses from the drop in Talaris Therapeutics' long position.
The idea behind Monte Rosa Therapeutics and Talaris Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Complementary Tools

Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals